- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03015506
Measuring the Glycemic Index of Pulse Based Breads
April 26, 2017 updated by: Glycemic Index Laboratories, Inc
The objective of this study is to determine the glycemic index of 4 pulse-based breads in at least 10 normal healthy human volunteers.
Participants will be studied in the morning on 6 separate days after overnight fasts.
On the first and last days they will consume a test meal consisting of about 2 slices of white bread (50g carbohydrate) and on the other 4 days they will consume 2-3 slices (50g carbohydrate) from 4 different test breads containing starch obtained from pulses (beans and/or lentils).
Blood glucose will be measured at intervals over 2 hours.
Glycemic index is calculated as 0.71 times F/WB where F is the incremental area under the curve of blood glucose (AUC) after each test bread and WB is the mean AUC after white bread.
Study Overview
Study Type
Interventional
Enrollment (Actual)
12
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 75 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- participants in good health
Exclusion Criteria:
- known history of HIV
- known history of diabetes
- history of hepatitis within the last 3 months
- heart condition requiring hospitalization within 3 months
- use of medications or presence of any condition which in the opinion of the study physician, would increase the risk of harm to the subject or to others, or affect the results of the study.
- participants who cannot or will not comply with experimental procedures or the safety guidelines of Glycemic Index Laboratories, Inc.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: White Bread
Portion of bread containing 50g available carbohydrate (defined as total carbohydrate minus dietary fiber).
|
|
Experimental: Pea Bread
Portion of bread containing 50g available carbohydrate (defined as total carbohydrate minus dietary fiber) containing 18% (by weight) pea flour.
|
|
Experimental: Green Lentil Bread
Portion of bread containing 50g available carbohydrate (defined as total carbohydrate minus dietary fiber) containing 18% (by weight) green lentil flour.
|
|
Experimental: Red Lentil Bread
Portion of bread containing 50g available carbohydrate (defined as total carbohydrate minus dietary fiber) containing 18% (by weight) red lentil flour.
|
|
Experimental: Chickpea Bread
Portion of bread containing 50g available carbohydrate (defined as total carbohydrate minus dietary fiber) containing 18% (by weight) chickpea flour.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Glycemic Index
Time Frame: 120 minutes
|
Glycemic index is 0.71 times F/WB where F is the incremental area under the blood glucose response curve ignoring area below fasting (AUC) elicited by a pulse bread, and WB is the mean AUC elicited by White Bread.
AUC is calculated using the trapezoid rule from 2 measures of fasting blood glucose taken 5 minutes apart (the average of these measures is taken to be fasting blood glucose) and measures of blood glucose at 15, 30, 45, 60, 90 and 120 minutes after starting to eat.
The mean of the values for each pulse bread in each subject is the glycemic index.
|
120 minutes
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Incremental area under the blood glucose response curve
Time Frame: 120 minutes
|
Incremental area under the blood glucose response curve ignoring area below fasting (AUC) is calculated using the trapezoid rule from 2 measures of fasting blood glucose taken about 5 minutes apart (the average of these measures is taken to be fasting blood glucose) and measures of blood glucose at 15, 30, 45, 60, 90 and 120 minutes after starting to eat.
|
120 minutes
|
Peak blood glucose concentration (Cmax)
Time Frame: 120 minutes
|
Cmax is the maximum of the blood glucose concentrations measured at 15, 30, 45, 60, 90 and 120 minutes after consumption of a test meal.
|
120 minutes
|
Peak rise of blood glucose
Time Frame: 120 minutes
|
The maximum of the blood glucose concentrations measured at 15, 30, 45, 60, 90 and 120 minutes after consumption of a test meal minus the fasting blood glucose concentration.
|
120 minutes
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2017
Primary Completion (Actual)
March 1, 2017
Study Completion (Actual)
March 1, 2017
Study Registration Dates
First Submitted
January 6, 2017
First Submitted That Met QC Criteria
January 9, 2017
First Posted (Estimate)
January 10, 2017
Study Record Updates
Last Update Posted (Actual)
April 28, 2017
Last Update Submitted That Met QC Criteria
April 26, 2017
Last Verified
January 1, 2017
More Information
Terms related to this study
Other Study ID Numbers
- 01E91-16-62508
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Carbohydrate Intolerance
-
University of TorontoGlycemic Index Laboratories, IncCompletedCarbohydrate IntoleranceCanada
-
Ausnutria Hyproca B.V.HM hospitalesCompleted
-
Augusta UniversityTerminatedDietary Fructose IntoleranceUnited States
-
University of LausanneUniversity of LiegeCompletedHereditary Fructose IntoleranceBelgium
-
Maastricht University Medical CenterPfizerCompleted
-
University of LausanneCompletedGlucose Metabolism Disorders | Fructose Metabolism, Inborn Errors | Hereditary Fructose Intolerance
-
Oregon Health and Science UniversityUniversity of Oregon; Oregon State UniversityRecruitingCarbohydrate IntoleranceUnited States
-
Texas A&M UniversityCurves InternationalCompletedCarbohydrate Intolerance
-
University of ReadingCompletedMilk IntoleranceUnited Kingdom
-
Purdue UniversityCompletedLactose Intolerance, Adult TypeUnited States
Clinical Trials on Bread
-
Glycemic Index Laboratories, IncUniversity of Guelph; Guelph Research and Development Centre, Agriculture and...Completed
-
KU LeuvenRecruitingAppetite Regulation | Energy IntakeBelgium
-
Newcastle-upon-Tyne Hospitals NHS TrustBiotechnology and Biological Sciences Research CouncilCompleted
-
Paulic Meunerie SAInstitut Polytechnique UniLaSalleCompleted
-
University of Eastern FinlandVTT Technical Research Centre of FinlandCompletedGlucose Metabolism Disorders | Inflammation | Intestinal Disorder
-
Organización Interprofesional Agroalimentaria de...Universidad de GranadaCompleted
-
West German Center of Diabetes and HealthBakery HinkelCompleted
-
Örebro University, SwedenCompleted
-
University of AberdeenCompletedHealthy | OverweightUnited Kingdom
-
University of AberdeenUnknownNon Coeliac Gluten SensitivityUnited Kingdom